![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Former GSK CEO to Co-Lead WHO’s COVID-19 Vaccine Effort
Former GSK CEO to Co-Lead WHO’s COVID-19 Vaccine Effort
![Vaccine needle](https://www.fdanews.com/ext/resources/test/Drug-Images4/Vaccine-needle-bottle.gif?t=1596243581&width=430)
Andrew Witty, the former CEO of GlaxoSmithKline (GSK), has been appointed to co-lead the World Health Organization’s efforts to develop a vaccine for COVID-19.
Witty was GSK’s CEO from 2008 to 2017, and he led the company’s vaccine development efforts. He is now CEO of Optum, a pharmacy benefits manager and healthcare services group owned by UnitedHealth Group.
Witty will take a leave of absence from Optum effective April 20 and will return to that role at the end of the year.
Upcoming Events
-
18Jul
-
21Oct